The influence of irbesartan on biomarkers of renal function and oxidative stress
Not Applicable
- Conditions
- hypertension
- Registration Number
- JPRN-UMIN000013065
- Lead Sponsor
- ational Defense Medical College
- Brief Summary
We could not see specific association betwee urine F-ABP and the administration of irbesartan in the first 10 patients. Then we stopped the trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(a) patietns exceeding or under the age limit (b) patietns in whom the side effect of irbesartan possibly occure (c) patietns with past heart failure (d) patietns with ejection fraction under 40% (e) patietns with other reasons not appropriate for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The changes of renal biomarker of liver-type fatty acid binding protein (L-FABP)
- Secondary Outcome Measures
Name Time Method